However, individuals with non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) may benefit from periodic monitoring to assess improvements in liver health as weight loss progresses
Hold the skin taut to prepare the muscle for injection
Gastrointestinal effects : Wegovy commonly causes nausea, vomiting, diarrhoea, and constipation, especially during dose escalation
Most patients begin noticing increased hunger by day 56, but the medication doesn't cause harmyou'll simply feel appetite return gradually
And it requires patients to understand that a prescription, however effective the medication it covers, is the beginning of a treatment plan rather than the whole of it
Interestingly, both of these families are not known as typical antimicrobials